275 related articles for article (PubMed ID: 25787187)
1. Multiple sclerosis: the role of melatonin and N-acetylserotonin.
Anderson G; Rodriguez M
Mult Scler Relat Disord; 2015 Mar; 4(2):112-23. PubMed ID: 25787187
[TBL] [Abstract][Full Text] [Related]
2. Effector and regulatory B cells in Multiple Sclerosis.
Staun-Ram E; Miller A
Clin Immunol; 2017 Nov; 184():11-25. PubMed ID: 28461106
[TBL] [Abstract][Full Text] [Related]
3. Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders.
Anderson G; Maes M
CNS Neurol Disord Drug Targets; 2014; 13(5):817-27. PubMed ID: 25012620
[TBL] [Abstract][Full Text] [Related]
4. Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Adamczyk-Sowa M; Pierzchala K; Sowa P; Polaniak R; Kukla M; Hartel M
J Physiol Pharmacol; 2014 Aug; 65(4):543-50. PubMed ID: 25179086
[TBL] [Abstract][Full Text] [Related]
5. The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
Duddy M; Palace J
Pract Neurol; 2016 Feb; 16(1):4-6. PubMed ID: 26430247
[No Abstract] [Full Text] [Related]
6. Multiple sclerosis disease-modifying therapy and pregnancy.
Miller AE
Mult Scler; 2016 May; 22(6):715-6. PubMed ID: 27207870
[No Abstract] [Full Text] [Related]
7. Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
Costello K
J Neurosci Nurs; 2013 Dec; 45(6 Suppl 1):S14-23. PubMed ID: 24217187
[TBL] [Abstract][Full Text] [Related]
8. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T;
JAMA Neurol; 2015 Apr; 72(4):405-13. PubMed ID: 25665031
[TBL] [Abstract][Full Text] [Related]
9. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.
Anderson G; Rodriguez M; Reiter RJ
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694154
[TBL] [Abstract][Full Text] [Related]
10. The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
McKay FC; Gatt PN; Fewings N; Parnell GP; Schibeci SD; Basuki MA; Powell JE; Goldinger A; Fabis-Pedrini MJ; Kermode AG; Burke T; Vucic S; Stewart GJ; Booth DR
Clin Immunol; 2016 Feb; 163():96-107. PubMed ID: 26762769
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotonin and melatonin.
Yocca FD; de Paul Lynch V; Friedman E
J Pharmacol Exp Ther; 1983 Sep; 226(3):733-7. PubMed ID: 6193266
[TBL] [Abstract][Full Text] [Related]
13. The level of N-acetylserotonin and melatonin in the brain of male rats: diurnal variations and effects of pinealectomy.
Pang SF; Tang PL; Yu HS; Yip MK
J Exp Zool; 1982 Feb; 219(3):271-6. PubMed ID: 7199559
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.
Anderson G; Rodriguez M
Eur J Neurol; 2011 May; 18(5):680-5. PubMed ID: 21118329
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan hydroxylase is modulated by L-type calcium channels in the rat pineal gland.
Barbosa R; Scialfa JH; Terra IM; Cipolla-Neto J; Simonneaux V; Afeche SC
Life Sci; 2008 Feb; 82(9-10):529-35. PubMed ID: 18221757
[TBL] [Abstract][Full Text] [Related]
16. Pineal gland as a model to elucidate the primary mode of action of alpha-methyldopa: alpha-methyldopa induces an increase in the synthesis of N-acetylserotonin and melatonin levels by the rat pineal gland.
Welman AD; Daya S
J Neurosci Res; 1990 May; 26(1):115-9. PubMed ID: 2359145
[TBL] [Abstract][Full Text] [Related]
17. Relations between mood characteristics, circadian preferences, and functionality in multiple sclerosis.
Ozdemir PG; Milanlioglu A; Boysan M; Cilingir V; Aydin N; Atli A
Int J Psychiatry Clin Pract; 2015 Jun; 19(2):148-54. PubMed ID: 25363199
[TBL] [Abstract][Full Text] [Related]
18. Negative correlation of age and the levels of pineal melatonin, pineal N-acetylserotonin, and serum melatonin in male rats.
Pang SF; Tang F; Tang PL
J Exp Zool; 1984 Jan; 229(1):41-7. PubMed ID: 6538220
[TBL] [Abstract][Full Text] [Related]
19. Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Kennedy P
J Neurosci Nurs; 2013 Dec; 45(6 Suppl 1):S3-13. PubMed ID: 24217189
[TBL] [Abstract][Full Text] [Related]
20. The role of melatonin in Multiple Sclerosis.
Skarlis C; Anagnostouli M
Neurol Sci; 2020 Apr; 41(4):769-781. PubMed ID: 31845043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
